683 Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-222,603
| Closed | -$407K | – | 266 |
|
|
2022
Q1 | $407K | Sell |
222,603
-81,208
| -27% | -$148K | 0.02% | 188 |
|
|
2021
Q4 | $428K | Buy |
+303,811
| New | +$428K | 0.02% | 202 |
|
|
2021
Q1 | – | Sell |
-2,000,000
| Closed | -$3.9M | – | 155 |
|
|
2020
Q4 | $3.9M | Hold |
2,000,000
| – | – | 0.18% | 68 |
|
|
2020
Q3 | $4.78M | Hold |
2,000,000
| – | – | 0.35% | 44 |
|
|
2020
Q2 | $5.86M | Hold |
2,000,000
| – | – | 0.47% | 37 |
|
|
2020
Q1 | $5.76M | Buy |
2,000,000
+1,300,000
| +186% | +$3.74M | 0.68% | 28 |
|
|
2019
Q4 | $2.8M | Sell |
700,000
-724,378
| -51% | -$2.9M | 0.32% | 44 |
|
|
2019
Q3 | $6.34M | Hold |
1,424,378
| – | – | 0.7% | 25 |
|
|
2019
Q2 | $5.51M | Buy |
1,424,378
+619,378
| +77% | +$2.4M | 0.5% | 34 |
|
|
2019
Q1 | $3.05M | Hold |
805,000
| – | – | 0.28% | 52 |
|
|
2018
Q4 | $1.92M | Hold |
805,000
| – | – | 0.12% | 60 |
|
|
2018
Q3 | $5M | Sell |
805,000
-80,000
| -9% | -$497K | 0.32% | 36 |
|
|
2018
Q2 | $3.99M | Buy |
885,000
+80,000
| +10% | +$361K | 0.27% | 48 |
|
|
2018
Q1 | $3.7M | Sell |
805,000
-145,000
| -15% | -$667K | 0.33% | 46 |
|
|
2017
Q4 | $3.05M | Buy |
+950,000
| New | +$3.05M | 0.26% | 54 |
|